RHENMAN & PARTNERS ASSET MANAGEMENT AB Horizon Therapeutics Public Limited Company Transaction History

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:

$8.10M
portfolio value

RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:

-22.40%
quarter

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -60.04% -195.29K shares -17.84M $61.89 130K
Q2 2022 share Decrease -3.14% -10.53K shares -9.38M $79.76 325.29K
Q1 2022 share Decrease -20.98% -89.16K shares -10.67M $105.21 335.83K
Q4 2021 share Decrease -9.57% -45K shares -5.47M $108.26 425K
Q3 2021 share Decrease -10.48% -55K shares 2.32M $109.54 470K
Q2 2021 share Decrease -11.76% -70K shares -5.60M $93.64 525K
Q1 2021 share Decrease -0.83% -5K shares 10.87M $92.04 595K
Q4 2020 share Decrease -13.67% -95K shares -10.09M $73.15 600K
Q3 2020 share Decrease -7.33% -55K shares 12.30M $77.68 695K
Q2 2020 share Decrease -25.00% -250K shares 12.06M $55.58 750K
Q1 2020 share Increase +29.03% 225K shares 1.56M $29.62 1M
Q4 2019 share Decrease -24.39% -250K shares 144K $36.2 775K
Q3 2019 share Increase 0.00% 1.02M shares 27.91M $27.23 1.02M